Picture of Athenex logo

ATNXQ — Athenex News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Athenex To Acquire Kuur Therapeutics To Expand Cell Therapy Development With Off-The-Shelf Engineered Car-Nkt Platform

May 4 (Reuters) - Athenex Inc  ATNX.O :
    * ATHENEX TO ACQUIRE KUUR THERAPEUTICS TO EXPAND CELL
THERAPY
DEVELOPMENT WITH OFF-THE-SHELF ENGINEERED CAR-NKT PLATFORM
    * ATHENEX INC - DEAL FOR TOTAL POTENTIAL CONSIDERATION OF
$185
MILLION
    * ATHENEX INC - UNDER TERMS OF AGREEMENT, ATHENEX WILL PAY
$70
MILLION UPFRONT TO KUUR SHAREHOLDERS AND CERTAIN OF ITS FORMER
EMPLOYEES AND DIRECTORS
    * ATHENEX - TOTAL POTENTIAL CONSIDERATION OF $185 MILLION,
COMPRISING $70 MILLION UPFRONT PRIMARILY IN ATHENEX STOCK, &
$115 MILLION IN DEVELOPMENT MILESTONES

Source text for Eikon:  ID:nGNX8Kbtl7 
Further company coverage:  ATNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Athenex

See all news